🧪 Anti-Citrullinated Protein Antibodies (ACPAs): These autoantibodies often precede the onset of clinical rheumatoid arthritis (RA) and are associated with more aggressive disease. They are highly useful as both diagnostic and prognostic tools.
ℹ️ About
- ⏳ Turnaround time for results may be several weeks.
- 🔬 ACPAs (anti-CCP antibodies) are detected using laboratory assays.
🧬 Aetiology
- 🔄 In >90% of RA patients, the immune system produces autoantibodies against citrullinated proteins (arginine → citrulline modification).
- 🧠 This immune response may drive the inflammation seen in RA, as citrullinated proteins and the enzymes generating them are abundant in inflamed synovium.
- 🧪 Anti-CCP assays use synthetic cyclic citrullinated peptides and are both more sensitive and more specific than rheumatoid factor (RF).
- 📊 NICE (2009) still recommends RF as a first-line test (cost-effectiveness), but anti-CCP is superior diagnostically.
- ⚠️ A positive anti-CCP in adults is highly predictive of RA and may appear years before clinical symptoms.
- 🔍 A minority of RA patients remain anti-CCP negative, though newer assays continue to reduce this group.
Clinical Use
- 👩⚕️ Used in patients with suspected rheumatoid arthritis, especially when RF is negative or diagnosis is uncertain.
- 📉 Positive anti-CCP predicts more severe erosive disease and worse long-term outcomes.
🔎 Investigations
- 💡 Assay: Fluorescence enzyme-linked immunoassay (FEIA, e.g. Phadia ImmunoCAP 250).
- 🧾 Reference ranges:
- ❌ Negative = < 7 U/mL
- ⚖️ Equivocal = 7–10 U/mL
- ✅ Positive = > 10 U/mL
- 📈 Assay detection range: 0.4 to > 340 U/mL.
References
- 📖 NICE Clinical Knowledge Summaries: Rheumatoid Arthritis
- 📚 NCBI – Anti-CCP and RA diagnosis